Zimbabwe Pharmaceuticals and Healthcare Report Q1 2015

Business Monitor International
December 17, 2014
84 Pages - SKU: BMI5416378
Countries covered: Zimbabwe

Zimbabwe Pharmaceuticals and Healthcare Report Q1 2015

BMI View: The World Health Organization's approval of a quality control laboratory for medicines inZimbabwe is a positive step for the country's pharmaceutical market. It will help to reduce the proportion ofcounterfeit medicines in circulation and increase the country's attractiveness to multinational drugmakers.Nevertheless, for the foreseeable future the dire economic and political outlook, reduced healthcare budgetand underdeveloped local manufacturing industry will continue to limit investment.

Headline Expenditure Projections

Pharmaceuticals: USD378mn in 2013 to USD388mn in 2014; +2.8% in US dollar terms. Forecastrevised up from last quarter's projections to better suit current market conditions.

Risk/Reward Index

In BMI's RRI table for Q1 2015, Zimbabwe scores 29 out of 100, unchanged from the previous quarter. Thecountry ranks 29th out of the 31 markets assessed in the Middle East and Africa (MEA) region.



More Prescription Drugs reports by Business Monitor International

Taiwan Pharmaceuticals and Healthcare Report Q1 2015 by Business Monitor International
Taiwan Pharmaceuticals and Healthcare Report Q1 2015BMI View: Taiwan is one of the most attractive and stable prospects in the region for pharmaceutical andhealthcare investment, ...
Switzerland Pharmaceuticals and Healthcare Report Q1 2015 by Business Monitor International
Switzerland Pharmaceuticals and Healthcare Report Q1 2015BMI View: The Swiss government will need to develop policies to maintain the country's long-termattractiveness as a site for ...
Sudan Pharmaceuticals and Healthcare Report Q1 2015 by Business Monitor International
Sudan Pharmaceuticals and Healthcare Report Q1 2015BMI View: The already depreciating Sudanese pound will come under further strain should oil pricescontinue their decline as oil ...
Saudi Arabia Pharmaceuticals and Healthcare Report Q1 2015 by Business Monitor International
Saudi Arabia Pharmaceuticals and Healthcare Report Q1 2015BMI View: We expect heavy investment into Saudi Arabia's healthcare sector to continue, particularly asthe government sees the ...
See all reports like this >>

More Zimbabwe Prescription Drugs reports

Zimbabwe Pharmaceuticals and Healthcare Report Q4 2014 by Business Monitor International
Zimbabwe Pharmaceuticals and Healthcare Report Q4 2014BMI View: Zimbabwe's poor economic outlook, in addition to the government announcing budget cuts tohealthcare, means that we do ...
Pharmaceuticals and Healthcare Report - Zimbabwe Q3 2014 by Business Monitor International
Zimbabwe Pharmaceuticals and Healthcare Report Q3 2014BMI View: Zimbabwe's pharmaceutical industry suffers significantly from the country's frail economy andongoing political instability, with neither expected to ...
See all reports like this >>

 

SELECT A LICENSE

    Report with 3 quarterly updates  USD 1,295  
    Report with 3 quarterly updates
3 User License
  USD 1,945  
    Report with 3 quarterly updates
5 User License
  USD 2,500  
    Report with 3 quarterly updates
Departmental/Site License
  USD 2,995  
    Global Site License Fulfilled by Publisher  USD 6,995  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!